MODELS
TRANSLATIONAL DISEASE MODELS
We offer a variety of patient derived models. Whether from our biobank, from that of our partners or commercially sourced, we strive to use cells that generate the disease model most appropriate to test your drugs. By reflecting patient diversity, our models help uncover targeted insights across diseases and cell types.
ONCOLOGY and IMMUNO-ONCOLOGY MODELS
We have experience of culturing and testing a variety of cancer indications in 3D, both patient-derived and not, continuously increasing our offering across indications and cancer type.
Glioblastoma
Breast cancer
Endometrial cancer
Colorectal cancer
Ovarian cancer
Prostate cancer
Lung cancer
Other indications available soon
WOMEN’S HEALTH MODELS
We have developed 3D translational models of endometriosis, fibroid disease and of the healthy uterine walls. Our technology enables testing of hormonal treatments an d contraceptive, providing answers to largely understudied chronic gynaecological diseases.
MORE IN DEVELOPMENT
OUR technology is disease agnostic, having obtained proof-of-concept data with liver samples, iPSC-cells and contractile cells. Stay tuned for new disease models coming soon. If you are interested in developing new models, please get in touch.
